Extended-release tablets are designed to release medicine over time, so they should not be crushed, split, or chewed unless the product instructions specifically allow it
Tirzepatide is given subcutaneously once a week and was examined in four worldwide phase III randomized, placebo-controlled clinical trials as part of the SURMOUNT Program, which also includes lifestyle modification
10.1016/j.fct.2021.112618 49
(a-c): data represented as mean +/- SEM
On the basis of these parameters, the required sample size has been obtained equal to 9
Hydration Support To hydrate skin, the formulation incorporates plant-derived Squalane (which makes up over 50% of the formulation), as well as Glycogen and Zizanoic Vetiver, to help restore skins hydration reservoirs